Search Results

You are looking at 81 - 90 of 561 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Mary K. Hayes, Mayra Frau, Erica Bloomquist, and Heather Wright

surgery based on the intraoperative pathology of the excised LN. An excellent response post-NACT with a “normalized” BX LN is often poorly visualized and limits LN LOC to 72% success rate. Therefore, a clinical practice of LN BX and up front WFL, when the

Full access

Tara M. Breslin, Marcy Waldinger, and Samuel M. Silver

; pathology; and radiology. The mission of the BCTF is to implement evidence-based evaluation and management strategies for patient care at the UMCCC Breast Care Center. The results were then shared at the Breast Care Center Educational Forum with the entire

Full access

Saman S. Karimi and Dr. Maria F. Gonzalez

Introduction: Efficiency and adequacy in reporting diagnoses and molecular alterations in surgical pathology specimens have a direct impact on patient care. We conducted a retrospective study to assess the turnaround time (TAT) of rectal specimens

Full access

Margaret Tempero

, which now has approval for its CDx diagnostic test. I've been pretty public about my endorsement of FDA approval of diagnostics. 1 Not everyone agrees with this position, though, especially pathology groups who, in their defense, have made big

Full access

Nandan Maruti Shanbhag and Joycelyn Condace Phillip

Breast. Pathology: 80% are of Invasive Ductal Histology with about 9% Ductal Carcinoma Insitu. Stage: 55% are Advanced Breast Cancers. Hormone Status: More than 50% of the Tumours were Hormone Positive and Her2Neu Negative. Triple Negative Breast Cancer

Full access

Barbara S Schwartzberg, A. M. Nisar Syed, and Craig Wengler

unplanned risk-adjusted post-IORT WBRT. Pt outcomes based on BMI and the unplanned need (positive lymph nodes, tumor size > 30 mm on final pathology) for post-IORT WBRT were analyzed in the IRB-approved single arm prospective multi-institution ExBRT trial

Full access

José Alfonso Leiva Centeno, Patricio Orbe Villota, Juan José de Benito, Leonardo Víctor Tavip, María Belén Leithold, Sandro Mario Varea, and Pedro Gustavo Minuzzi

relation to several of the pre-surgical variables, as international society of urological pathology (ISUP) grade, PC risk group, and number of positive cores, compared to patients who did not present PNI. A similar situation was observed in post

Full access

Qingqing Zhou, Chenchen Zhu, Zhen Shen, Jing Zhu, Tianjiao Zhang, Min Li, Jiwei Qin, Lili Qian, Chuan Chen, Hanyuan Liu, Zhihao Xu, Dabao Wu, Björn Nashan, and Ying Zhou

surgery. Patients with clear cell ovarian cancer had the highest incidence of VTE (26.32%) among all the pathology types. 81.82% of patients with VTE were at advanced stage (III and IV). After the primary cytoreduction surgery, 7.79% of patients developed

Full access

Kristen Kelley, Audrey York, Benjamin Haaland, Xuechen Wang, Shiven Patel, Adriana Coletta, and Christos Vaklavas

, pathology, and disease recurrences were collected. Stratification occurred by stage, age, receptor status, and treatment. Univariate and multivariate logistic models were used to investigate the relationship between endpoints and dosing time. Contingency

Full access

Benigno Emmanuel Rodriguez Soto, Lorena López Zepeda, Alejandro Noguez Ramos, Daniela Vázquez Juarez, Daniela Shveid Gerson, Yazmin Carolina Blanco Vázquez, Samuel Rivera Rivera, Alberto Villalobos Prieto, Gabriela Olivia Regalado Porras, Ivonne Salcedo Sullk, Fernando Pérez Zincer, Christian Patricio Camacho Limas, Juan Alberto Serrano Olvera, Álvaro Aguayo González, Guillermo Manuel Olivares Beltrán, and Raquel Gerson Cwilich

. The median age was 52.2 years (22-79). Within the characteristics of the pathology, 34 patients had infiltrating ductal carcinoma, 8 infiltrating lobular and 2 mixed histology. Regarding the metastasis pattern, 29 presented visceral and 15 non